Overview
ARA-290 (16mg) is a unique peptide derived from the beta-helix domain of erythropoietin (EPO), specifically engineered to promote blood vessel growth and aid in tissue repair. Unlike traditional EPO, ARA-290 does not stimulate blood cell formation, focusing instead on delivering pain relief and neuroprotection. This makes it a compelling choice for those dealing with diabetic neuropathy or similar conditions. With increasing research backing its benefits, ARA-290 is becoming a staple in the Biotech Peptides community.
Key Features
- Promotes blood vessel growth and repair
- Supports potential neuroprotective effects
- Does not stimulate blood cell formation
- Ideal for addressing diabetic neuropathy
- 16mg dosage for precise administration
Specifications
| Attribute | Details |
|---|---|
| Product Name | ARA-290 |
| Dosage | 16mg |
| Category | Biotech Peptides |
| Origin | Beta-helix domain of EPO |
FAQ
What is ARA-290 used for?
ARA-290 is primarily used for promoting blood vessel growth and repair, as well as providing neuroprotection, particularly in cases of diabetic neuropathy.
How should I take ARA-290?
It’s recommended to follow the dosage instructions provided by your healthcare professional. Typically, ARA-290 is administered via subcutaneous injection.
Are there any side effects?
While ARA-290 is generally considered safe, some individuals may experience mild side effects. It’s essential to consult with a healthcare provider before starting any new peptide regimen.
For a comprehensive selection of peptides, check out our Biotech Peptides. If you’re also interested in neuroprotective options, consider N-Acetyl Selank or Pentapeptide-18. Give your health the boost it needs and shop ARA-290 today!



